Brendan Hannah - Jun 4, 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
CHIEF BUSINESS OFFICER AND COO
Signature
/s/ Brendan Hannah
Stock symbol
QNCX
Transactions as of
Jun 4, 2024
Transactions value $
$30,834
Form type
4
Date filed
6/5/2024, 02:37 PM
Previous filing
Feb 2, 2024
Next filing
Aug 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $30.8K +56.1K +27.81% $0.55 258K Jun 4, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Employee Stock Option (right to buy) Options Exercise $0 -56.1K -54.17% $0.00 47.4K Jun 4, 2024 Common Stock 56.1K $0.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.